Literature DB >> 11168094

Comparison of the E test to the reference agar dilution method for antibiotic susceptibility testing of Clostridium difficile.

I Poilane1, P Cruaud, J C Torlotin, A Collignon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11168094     DOI： 10.1046/j.1469-0691.2000.00034-4.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  10 in total

1.  Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.

Authors:  T Norén; M Wullt; Thomas Akerlund; E Bäck; I Odenholt; L G Burman
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.

Authors:  Olle Aspevall; Annika Lundberg; Lars G Burman; Thomas Akerlund; Bo Svenungsson
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 3.  Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.

Authors:  Zhong Peng; Dazhi Jin; Hyeun Bum Kim; Charles W Stratton; Bin Wu; Yi-Wei Tang; Xingmin Sun
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

4.  Can metronidazole still be used for treatment of Clostridium difficile infections?

Authors:  Haihui Huang; Carl Erik Nord
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

5.  Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.

Authors:  Isabella A Tickler; Richard V Goering; Joseph D Whitmore; Ashley N W Lynn; David H Persing; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

Review 6.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

7.  Metronidazole resistance in Clostridium difficile is heterogeneous.

Authors:  T Peláez; E Cercenado; L Alcalá; M Marín; A Martín-López; J Martínez-Alarcón; P Catalán; M Sánchez-Somolinos; E Bouza
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

Review 8.  Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.

Authors:  Saeed S Banawas
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411

9.  Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection.

Authors:  Anne J Gonzales-Luna; Abiola O Olaitan; Wan-Jou Shen; Aditi Deshpande; Travis J Carlson; Kierra M Dotson; Chris Lancaster; Khurshida Begum; M Jahangir Alam; Julian G Hurdle; Kevin W Garey
Journal:  Open Forum Infect Dis       Date:  2021-07-08       Impact factor: 3.835

10.  Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region.

Authors:  Agatha N Jassem; Natalie Prystajecky; Fawziah Marra; Pamela Kibsey; Kennard Tan; Patricia Umlandt; Loretta Janz; Sylvie Champagne; Bruce Gamage; George R Golding; Michael R Mulvey; Bonnie Henry; Linda M N Hoang
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-03-29       Impact factor: 2.471
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.